Trials / Unknown
UnknownNCT02910245
Mercaptopurine Therapy in Ulcerative Colitis
Efficacy of Optimized Thiopurine Therapy in Ulcerative Colitis (OPTIC)
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 136 (estimated)
- Sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This project is a double-blind, randomized, placebo-controlled, multicenter trial in the Netherlands. The aim of this study is to investigate the therapeutic efficacy of optimized 6-mercaptopurine (6-MP) in ulcerative colitis patients. Therapeutic drug monitoring (TDM) will be performed in order to optimize treatment outcomes and objective endoscopic endpoints will be used.
Detailed description
Subjects will receive treatment with oral prednisone 40 mg/day for 2 weeks, followed by fixed tapering over 6 weeks. Half of the subjects will be randomized to concomitant 6-MP 1-1.5 mg/kg/day and half will receive concomitant placebo treatment. During the entire course of the trial all subjects will receive maintenance treatment with 5-ASA in an oral dose of at least 2 gram per day. Subjects will be subjected to one colonoscopy at baseline and one sigmoidoscopy in week 52 in order to assess endoscopic disease activity. Data will be collected using electronic case report forms (eCRF) with Castor EDC. Quality and data validation procedures will be applied to ensure the validity and accuracy of the clinical database. Monitoring of the study will be done according to the GCP guidelines and following a monitoring plan. The financier of the study, ZonMw Goed Gebruik Geneesmiddelen, has the right to perform an audit if seen necessary.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mercaptopurine (Purinethol) | |
| DRUG | Placebo | |
| DRUG | Mesalamine | |
| DRUG | Prednisone |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2022-04-30
- Completion
- 2022-04-30
- First posted
- 2016-09-22
- Last updated
- 2020-01-07
Locations
12 sites across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT02910245. Inclusion in this directory is not an endorsement.